Adamas scores $40M, Navy funds to tackle the flu | VentureBeat
DEALS.VENTUREBEAT.COM - Adamas Pharmaceuticals, one of Mohr Davidow Ventures‘ key life science investments, has raised $40 million in a fourth round of funding to develop antiviral treatments for the flu virus. Based in Emeryville, Calif., the company also just signed a research agreement with the U.S. Navy to accelerate drug development in this area.The funding is significant not only due to its size in a lean...
First tweeted by dealhorizon.
From the Front Page
Socialsafe.net
- Comments
- Tweets (9)
Tweets
Sorry there have been no tweets in the last 7 days.
